MT Group Surpasses 5,000 Customized Biospecimen Collections, Reinforcing Its Position as a Leading Specialty CRO for Prospective Human Tissue and Blood Procurement

MT Group: 23-year-old biospecimen CRO marks milestone with expanded capabilities for translational research, biomarker discovery, companion diagnostic development, and liquid biopsy validation across oncology and autoimmune programs LOS...

CHICAGO--(BUSINESS WIRE)--Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine, Yale New Haven Hospital (YNHH) and Memorial Sloan Kettering Cancer Center (MSK) today announced the...

Proscia: National group positions itself as key partner for biopharmaceutical research, strengthening its role in precision medicine MELBOURNE, FL and PHILADELPHIA — June 3, 2026 — NextGen Pathology, a national group of general and...

Mach7: Company to highlight enterprise imaging workflows, enterprise viewing, and digital pathology capabilities at Booth 608 BURLINGTON, Vt., June 1, 2026 /PRNewswire/ -- Mach7 Technologies (ASX:M7T), a provider of...

Indica Labs: Learn about the new HALO module designed to streamline analysis for ADC-focused assays Powering ADC Development with the New HALO® ADC Target Scoring Module Date: 16 June 2026 Time: 8:00 – 9:00 PDT | 11:00 –...

Indica Labs Webinar: Learn about the exciting new features in the 4.3 versions of HALO, HALO AI, and HALO Link! What is new in HALO®, HALO AI, and HALO Link 4.3? Date: 11 June 2026 Time: 8:00 – 9:00 PDT | 11:00 – 12:00...